JCO precision oncologyHumansFemaleOvarian NeoplasmsNeoadjuvant TherapyMiddle Aged
Early Clinical and Molecular Biomarkers in Patients With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: CHIVA Phase II GINECO Trial.
Félix Blanc-Durand, Benoit You, Yahia Adnani, Gaëtan De Rauglaudre, Isabelle Ray-Coquard, Pierre Combe, Cyril Abdeddaim, Florence Joly, Gwenaël Ferron, Clotilde Deldycke, Olivier Colomban, Marie-Christine Kaminsky, Jerome Meunier, Jerôme Alexandre, Coriolan Lebreton
Published: 202610.1200/PO-25-00414
Abstract
PURPOSE: Platinum-based chemotherapy and surgery are pivotal in managing ovarian cancer (OC), yet prognosis remains poor, and early biomarkers for platinum resistance are needed. The neoadjuvant setting provides an opportunity to evaluate tumor respo…
Preview only. Read the full abstract at the source